Hossam El Benawi/LinkedIn
Jan 5, 2026, 09:02
Hossam El Benawi: DOACs for Left Ventricular Thrombus
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn:
“See our Responce : “DOACs for Left Ventricular Thrombus: Persistent Equipoise Despite New Observational and Randomized Data”
Mayo Left ventricular Thrombus Multi-Site Study
Find more posts from Hossam El Benawi on Hemostasis Today.
-
Jan 8, 2026, 02:58Isabelle Mahé on Delphi Consensus on Aspects Relating to the Antithrombotic Therapy for Cancer Patients
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs